Transient low T cell response to streptococcal pyrogenic exotoxin-C in patients with Kawasaki disease. 1998

K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
Department of Pediatrics, Faculty of Medicine, Kagoshima University, Kagoshima City, Sakuragaoka, Japan.

Superantigens (SAs) are known to induce transient anergy followed by T cell activation. Recent reports have suggested that SAs are involved in the pathogenesis of Kawasaki disease (KD). In the present study, we investigated the peripheral T cell response to SAs by measuring proliferation and IL-2 production to determine whether the T cell anergy is induced by SAs in patients with KD. T cells were obtained from 45 Japanese patients with KD in different stages of the disease and were stimulated by streptococcal pyrogenic exotoxin (SPE)-A, SPE-C, and toxic shock syndrome toxin-1 (TSST-1). T cells from patients with KD in the acute or convalescent stage up to 2 mo showed significantly lower proliferation and IL-2 production than did T cells from healthy control subjects stimulated by SPE-C, but not SPE-A or TSST-1. The T cell response to SPE-C normalized within 1 y. The low T cell response to SPE-C in the acute stage correlated with a peak platelet count and the C-reactive protein-positive period. These findings suggest that the transient low T cell response to SPE-C in patients with KD may have been related to SA-induced anergy or disappearance of SPE-C-responding cells from the circulation. The present results suggested that SPE-C may be involved in the pathogenesis of KD.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D009080 Mucocutaneous Lymph Node Syndrome An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities. Kawasaki Disease,Lymph Node Syndrome, Mucocutaneous,Kawasaki Syndrome
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003289 Convalescence The period of recovery following an illness. Convalescences
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal

Related Publications

K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
March 2003, Pediatric research,
K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
March 1991, Infection and immunity,
K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
October 2023, Journal of dairy science,
K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
September 1988, Infection and immunity,
K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
June 1989, Journal of bacteriology,
K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
June 1973, Infection and immunity,
K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
January 2000, Methods in molecular medicine,
K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
November 1979, Infection and immunity,
K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
November 1976, Infection and immunity,
K Masuda, and S Takei, and Y Nomura, and H Imanaka, and K Sameshima, and M Yoshinaga
May 1977, Infection and immunity,
Copied contents to your clipboard!